08 February 2016
Researchers at Medical Biological Union (MBU), a biotech company in Novosibirsk, in Siberia, have come up with a new immune-enzyme test system that is said to be able to identify four of the world’s most dangerous viruses simultaneously, the Russian news agency TASS reported , citing Darya Popova, the developer’s head of marketing.
“Our analyzer enables us to look into blood serum for four socially critical diseases all together. These include HIV infection, C and B type hepatitis, and syphilis. It takes 90 minutes to get a result,” the news agency quoted the company spokesperson as saying.
The new system is reported to make it possible to search for specific antibodies in blood or for antigens to specific diseases in order to determine both root causes and stages of a medical condition.
Russia’s healthcare organizations have had to import such test systems thus far, with reagents bought separately. The weakening national currency has more than doubled the ruble-denominated cost of the system and the reagents since last December.
The Siberian alternative will cost just over 30% of the price of imports, Ms. Popova said.
She explained that the new analyzer and special reagents, also a proprietary solution developed by MBU, will enable physicians to take little time to diagnose a number of other diseases as well, such as chlamydia infection, parotitis, mycoplasmosis and TORCH infections, most dangerous to prenatal development of a fetus.
According to Ms. Popova, such systems could be used in blood donation centers, where a donor is tested for the above four infections anyway, and in any clinical laboratory.
“We have plans to set up serial production by mid-2016,” the MBU spokesperson said.
14 March 2024
26 February 2024
NovaMedica team wishes you a Merry Christmas and a Happy New Year!
26 December 2023
Research calls for greater investment in Alzheimer’s clinical trials
03 May 2024
Stress impact on protein particle formation for monoclonal antibody formulation
03 May 2024
Health Ministry registered Russian drug for ankylosing spondylitis
02 May 2024
Production of finished drugs in Russia grew by 13.8%
02 May 2024